Biontech SE
NASDAQ:BNTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biontech SE
NASDAQ:BNTX
|
DE |
|
A
|
Avi Ltd
JSE:AVI
|
ZA |
|
T
|
Tokyo Gas Co Ltd
DUS:TOG
|
JP |
|
C
|
CPT Drives And Power PCL
SET:CPT
|
TH |
Intrinsic Value
Is BNTX undervalued or overvalued?
See the intrinsic value estimate for Biontech SE and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
BNTX looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with BNTX’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Biontech Does
BioNTech is a biotechnology company that develops mRNA-based medicines, especially vaccines and cancer treatments. Its best-known product was the COVID-19 vaccine it co-developed with Pfizer, but the company’s main business is broader: it builds drug candidates that teach the body’s immune system to recognize viruses and tumors. It sells approved products where it has them, and it also earns money from partnerships, development payments, and shared profits with larger drug companies.
- Headquarters
- Germany DE
- Employees
- 7 807
- IPO date
- Oct 10, 2019
Biontech has no economic moat
Patients and health systems can choose other COVID-19 vaccines without costly lock-in, and Comirnaty does not become more valuable just because more people use it. BioNTech’s oncology medicines are still in development, while its vaccine and cancer-treatment markets have other suppliers, so the company has no current barrier that reliably keeps competitors from winning customers.
Read the full moat analysisLatest Earnings Call
- EPS
- −$3.03
- Expected
- −$2.58
- Surprise
- −17.4%
- Stock, day of the call
- −1.0%
Earnings Waterfall
Biontech SE
The intrinsic value for Biontech SE (BNTX) under the Base Case is hidden USD.
Compared with the current market price of 91.3315 USD, the stock appears hidden.